View More Recent Stories

Sep 5, 2025 06:13AM United Therapeutics Corp. (UTHR) PT Raised to $575 at Oppenheimer
Sep 4, 2025 06:01AM United Therapeutics Corp. (UTHR) PT Raised to $560 at UBS
Sep 2, 2025 03:43PM United Therapeutics (UTHR) call put ratio 1 call to 6.3 puts with a focus on October and November puts as share price up 33%
Sep 2, 2025 10:42AM United Therapeutics Corp. (UTHR) PT Raised to $564 at Jefferies
Sep 2, 2025 07:00AM United Therapeutics' Tyvaso meets primary endpoint in IPF study
Aug 27, 2025 08:06AM MannKind expands United Therapeutics partnership for second inhaled therapy
Aug 19, 2025 07:44AM UBS Reiterates Buy Rating on United Therapeutics Corp. (UTHR)
Aug 14, 2025 07:22AM Cantor Fitzgerald Reiterates Overweight Rating on United Therapeutics Corp. (UTHR)
Aug 13, 2025 05:23AM United Therapeutics Corp. (UTHR) PT Raised to $415 at UBS
Jul 31, 2025 06:42AM United Therapeutics Corp. (UTHR) PT Lowered to $400 at H.C. Wainwright
Jul 30, 2025 06:31AM United Therapeutics (UTHR) Misses Q2 EPS by 94c
Jun 30, 2025 07:56AM United Therapeutics Corp. (UTHR) PT Lowered to $385 at UBS
Jun 23, 2025 07:05AM United Therapeutics (UTHR) Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension
Jun 10, 2025 08:45AM Leerink on Insmed (INSM) as Shares Surge 26pct: 'we continue to view INSM as a core Rare Disease/blockbuster platform'
Jun 4, 2025 06:23AM Leerink Partners Reiterates Outperform Rating on United Therapeutics Corp. (UTHR)
Jun 2, 2025 01:38PM Raymond James on Liquidia Technologies (LQDA): 'we maintain our positive outlook for the simultaneous Yutrepia launches in PAH and PH-ILD'
May 7, 2025 09:45AM TD Cowen: 'We Continue to See United Therapeutics Corp. (UTHR) Shares as Undervalued'
May 1, 2025 05:17AM United Therapeutics Corp. (UTHR) PT Raised to $321 at BofA Securities
Apr 30, 2025 06:31AM United Therapeutics (UTHR) Tops Q1 EPS by 10c
Apr 25, 2025 07:04AM Wells Fargo Downgrades United Therapeutics Corp. (UTHR) to Equal Weight
Apr 21, 2025 08:25AM BofA Securities Upgrades United Therapeutics Corp. (UTHR) to Neutral
Feb 27, 2025 04:56AM United Therapeutics Corp. (UTHR) PT Lowered to $293 at Goldman Sachs
Feb 26, 2025 06:33AM United Therapeutics (UTHR) Misses Q4 EPS by 49c
Feb 3, 2025 07:00AM United Therapeutics (UTHR) Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Dec 17, 2024 07:05AM United Therapeutics (UTHR) Announces Successful World’s First UKidney Transplant
Oct 31, 2024 07:04AM United Therapeutics Corp. (UTHR) PT Raised to $344 at Ladenburg Thalmann
Oct 31, 2024 06:44AM United Therapeutics Corp. (UTHR) PT Raised to $425 at H.C. Wainwright
Oct 30, 2024 06:33AM United Therapeutics (UTHR) Misses Q3 EPS by 14c
Oct 8, 2024 06:09AM LifeSci Capital Reiterates Outperform Rating on Liquidia Technologies (LQDA)
Sep 23, 2024 06:00AM United Therapeutics Corp. (UTHR) PT Raised to $432 at Jefferies
Aug 28, 2024 07:53AM United Therapeutics Corp. (UTHR) PT Raised to $575 at Oppenheimer
Aug 20, 2024 04:53AM United Therapeutics Corp. (UTHR) PT Raised to $380 at Wells Fargo
Aug 20, 2024 04:51AM Goldman Sachs Reiterates Neutral Rating on United Therapeutics Corp. (UTHR)
Aug 19, 2024 07:29AM TD Cowen Reiterates Buy Rating on United Therapeutics Corp. (UTHR)
Jul 31, 2024 06:35AM United Therapeutics (UTHR) Misses Q2 EPS by 63c
Jul 25, 2024 06:50AM United Therapeutics Corp. (UTHR) PT Raised to $400 at H.C. Wainwright
Jul 11, 2024 07:40AM United Therapeutics Corp. (UTHR) PT Raised to $350 at TD Cowen
Jul 11, 2024 03:17AM Morgan Stanley Downgrades United Therapeutics Corp. (UTHR) to Equalweight
Jul 8, 2024 02:14PM United Therapeutics Corp. (UTHR) PT Raised to $350 at Argus
Jul 8, 2024 10:19AM United Therapeutics Corp. (UTHR) PT Raised to $370 at UBS
Jun 27, 2024 07:02AM United Therapeutics (UTHR) Appoints Jan Malcolm to its Board
Jun 27, 2024 05:10AM United Therapeutics Corp. (UTHR) PT Lowered to $262 at BofA Securities
Apr 10, 2024 02:56PM Grow your wealth: UBS reveals top long-term stock picks
Sep 19, 2017 09:00AM Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds
View More Recent Stories